News

Qilu Ranks 17th in Top 100 in China’s Medical and Pharmaceutical Industry

ABOUT US

News

Qilu Ranks 17th in Top 100 in China’s Medical and Pharmaceutical Industry

Release time：

2011-07-07

List of the 6^TH Top 100 China’s Pharmaceutical Industry was released by South Medical and Pharmaceutical Economy Institute and Medicine Economic News. Qilu is among the best and ranks the 17^th. The Top 100 enterprises are mainly evaluated by annual sales revenue. It can show the core competitiveness of the enterprises.

Qilu is identified as the first group of innovation pilot enterprised in Shandong Province

Qilu's Provincial Key Laboratory for 'Small Molecule Targeted Drugs' Approved by the Experts's Argu

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list